Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

NCT00354367 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Certolizumab pegol

Sponsor

UCB Pharma